Eglucent Mix 25 Kwikpen

Composition of Eglucent Mix 25 Kwikpen

Eglucent Mix 25 Kwikpen contains Insulin lispro protamine suspension 25% + Insulin lispro 75% (100 IU/mL). It belongs to the Insulin analogue (premixed: insulin lispro + insulin lispro protamine) class of medicines.

Uses of Eglucent Mix 25 Kwikpen

Treatment of diabetes mellitus (type 1 and type 2) to improve blood glucose control when a premixed rapid-acting insulin regimen is indicated

Key benefits

• Controls post‑meal and between‑meal blood glucose
• Convenient premixed insulin option
• Helps reduce HbA1c with regular use
• Pen device enables accurate dosing and easier administration

How Eglucent Mix 25 Kwikpen works

This is a premixed insulin analogue containing rapid-acting insulin lispro and intermediate-acting insulin lispro protamine. The lispro component covers post‑meal blood sugar spikes, while the protamine component provides longer basal coverage between meals and overnight.

How to take Eglucent Mix 25 Kwikpen

For subcutaneous injection using the prefilled 3 mL KwikPen as prescribed by the doctor. Typically injected within 15 minutes before a meal or immediately after a meal; dose and timing depend on blood glucose, diet and activity. Gently roll/rotate the pen to resuspend until uniformly cloudy before use; do not use if clumped or not uniformly mixed. Rotate injection sites (abdomen, thigh, upper arm, buttock); do not inject into a vein or muscle. Use a new needle each time and do not share the pen.

Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.

Missed dose and overdose

If you miss a dose

Contact your doctor or diabetes nurse for advice — do not take a double dose to make up for a missed injection.

If you take too much

An overdose of this medicine can cause severe low blood sugar, leading to fits or unconsciousness — this is a medical emergency. Do not wait for symptoms to appear — go to the nearest emergency department and take the pack or strip with you.

Side effects of Eglucent Mix 25 Kwikpen

Most side effects of Eglucent Mix are mild and settle as the body adjusts. Reported side effects include:

• Hypoglycaemia (low blood sugar)
• injection site reactions (pain
• redness
• swelling)
• weight gain
• lipodystrophy (skin thickening/pitting at injection site)
• rash
• itching
• peripheral oedema

Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.

Safety advice for Eglucent Mix 25 Kwikpen

Warnings and precautions

Risk of severe hypoglycaemia—carry fast-acting glucose and monitor sugars regularly. Do not use during episodes of hypoglycaemia. Dose adjustments may be needed with changes in meals, exercise, illness, stress, or when switching from another insulin. Use caution in kidney or liver impairment; insulin requirements may change. Watch for allergic reactions; seek urgent care for breathing difficulty or widespread rash. Avoid injecting into areas of lipodystrophy. If used with pioglitazone, monitor for fluid retention/heart failure symptoms.

Do not take Eglucent Mix if

Not for anyone with a known allergy to this medicine or to any ingredient in the pack. Not to be used during an episode of low blood sugar.

Interactions with other medicines

Other antidiabetics (sulfonylureas, GLP-1 RAs) may increase hypoglycaemia risk; corticosteroids, thiazide diuretics, thyroid hormones, sympathomimetics may raise glucose and increase insulin needs; beta-blockers can mask hypoglycaemia symptoms; alcohol may cause unpredictable glucose changes; ACE inhibitors/ARBs and salicylates may enhance glucose-lowering; MAO inhibitors may increase hypoglycaemia risk; pioglitazone may increase risk of oedema/heart failure when combined with insulin

How to store Eglucent Mix 25 Kwikpen

Store unopened pens refrigerated at 2–8°C; do not freeze and keep away from the freezer compartment. Protect from light. After first use, store at room temperature (below 30°C) and use within the period stated on the pack; keep cap on and do not store with needle attached. Keep out of reach of children.

Expert advice for Eglucent Mix 25 Kwikpen

Keep an unopened supply in the fridge and the pen in use at room temperature, away from direct sunlight. Always carry a fast-acting sugar source. Check your sugar as your doctor has instructed, and keep a record to take to appointments.

Manufacturer and class

Manufacturer:

LUPIN LAB

Therapeutic class:

Hormone / Endocrine

Drug class:

Insulin analogue (premixed: insulin lispro + insulin lispro protamine)